Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chemicals

Download PDF
Federal RegisterMay 19, 2017
82 Fed. Reg. 23070 (May. 19, 2017)

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before July 18, 2017.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:

The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.

In accordance with 21 CFR 1301.33(a), this is notice that on March 7, 2017, American Radiolabeled Chemicals, Inc., 101 Arc Drive, Saint Louis, Missouri 63146 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Controlled substance Drug code Schedule
Gamma Hydroxybutyric Acid 2010 I
Ibogaine 7260 I
Lysergic acid diethylamide 7315 I
Tetrahydrocannabinols 7370 I
Dimethyltryptamine 7435 I
1-[1-(2-Thienyl)cyclohexyl]piperidine 7470 I
Dihydromorphine 9145 I
Heroin 9200 I
Normorphine 9313 I
Amphetamine 1100 II
Methamphetamine 1105 II
Amobarbital 2125 II
Phencyclidine 7471 II
Phenylacetone 8501 II
Cocaine 9041 II
Codeine 9050 II
Dihydrocodeine 9120 II
Oxycodone 9143 II
Hydromorphone 9150 II
Ecgonine 9180 II
Hydrocodone 9193 II
Meperidine 9230 II
Metazocine 9240 II
Methadone 9250 II
Dextropropoxyphene, bulk (non-dosage forms) 9273 II
Morphine 9300 II
Oripavine 9330 II
Thebaine 9333 II
Oxymorphone 9652 II
Phenazocine 9715 II
Carfentanil 9743 II
Fentanyl 9801 II

The company plans to manufacture small quantities of the listed controlled substances as radiolabeled compounds for biochemical research.

Dated: May 15, 2017.

Louis J. Milione,

Assistant Administrator.

[FR Doc. 2017-10240 Filed 5-18-17; 8:45 am]

BILLING CODE P